Sales rise 0.45% to Rs 168.10 crore
Sales decline 50.00% to Rs 0.01 crore
PAT for Q4FY22 was reported at Rs8,860 crore as compared to Rs6,734 crore in Q4FY21, up by 31.60% yoy.
Sales decline 70.13% to Rs 4.02 crore
Sales rise 39.96% to Rs 2952.75 crore
Dixon Technologies (India) surged 12.08% to Rs 3836 after the companys consolidated net profit jumped 43% to Rs 63.13 crore on a 40% rise in revenues from operations to Rs 2,952.75 crore in Q4 FY22 over Q4 FY21.
According to IQVIA MAT March 2022 data, the US market for Ibuprofen Oral Suspension USP, 100 mg/5 mL is approximately US$ 66 million.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
